Argenx (ARGX) announced the discontinuation of its Phase 3 UplighTED studies for efgartigimod SC in Thyroid Eye Disease (TED) after an interim analysis by an Independent Data Monitoring Committee (IDMC) indicated futility.
United States crypto regulation is entering a new phase after the Commodity Futures Trading Commission announced it would withdraw legacy digital asset guidance seen as misaligned with today’s market realities.
The decision, confirmed on 11 December, signals a regulatory pivot that could reduce compliance burdens and widen institutional access to crypto markets across the country.
Standard Chartered and Coinbase have expanded their strategic partnership to build trading, custody and financing infrastructure for institutional cryptocurrency clients.
The British multinational bank said the collaboration will focus on developing secure and compliant digital asset services tailored to large financial institutions.
Natera (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, and MEDSIR (Medica Scientia Innovation Research), a global leader in oncology research, today announced their collaboration on the MiRaDoR (NCT05708235) study.
Acadia Pharmaceuticals (NASDAQ:ACAD) announced today that the U.S. Food and Drug Administration (FDA) has approved DAYBUE® STIX (trofinetide) for oral solution, a new dye- and preservative-free powder formulation of trofinetide for the treatment of Rett syndrome in both adult and pediatric patients aged two years and older.
Relay Therapeutics (NASDAQ:RLAY) presented promising subset efficacy data from its ReDiscover program at the 2025 San Antonio Breast Cancer Symposium (SABCS), showcasing the combination of zovegalisib (RLY-2608) and fulvestrant in a cohort of 52 patients with estrogen receptor-positive breast cancer.
The United States has taken a landmark step in financial regulation after the Office of the Comptroller of the Currency granted conditional approval for five leading crypto companies to operate as national trust banks.
Ripple, Circle, Paxos, BitGo and Fidelity Digital Assets are now set to enter the federal banking system, marking one of the most significant regulatory endorsements of the digital asset sector to date.
Market focus has shifted to the Federal Reserve’s January 28, 2026 meeting after last week’s rate cut, with traders strongly signalling expectations of no further change.
Futures markets indicate policymakers are likely to hold the target federal funds rate steady rather than pursue another adjustment.
Ethereum (CRYPTO:ETH) continued to trade firmly above a key technical support zone, as analysts point to signs of renewed confidence from large investors and institutions.
Market observers said ETH has been consolidating below the $3,200 level, a price area widely viewed as critical for determining its next major directional move.
Artrya (ASX:AYA), a medical technology company commercialising its Salix AI-powered cloud platform for near real-time, point-of-care assessment and management of coronary artery disease, has announced that Tanner Health has commenced commercial use of the Salix Coronary Plaque module, generating the first fee-per-scan revenues for the company.
